Thorsten Steiner
Overview
Explore the profile of Thorsten Steiner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
168
Citations
5946
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tsivgoulis G, Katsanos A, Romoli M, Sarraj A, Krogias C, Karapanayiotides T, et al.
J Neurol Neurosurg Psychiatry
. 2025 Mar;
PMID: 40089306
Background: Current international guidelines suggest andexanet alfa (AA) for the management of factor Xa inhibitor-associated intracranial haemorrhage (ICH). However, those recommendations are based on low-quality evidence and there is uncertainty...
2.
Ovesen C, Purrucker J, Grundtvig J, Mikkelsen T, Gluud C, Jakobsen J, et al.
Scand J Trauma Resusc Emerg Med
. 2025 Feb;
33(1):19.
PMID: 39905505
Background: Swift reversal of oral anticoagulation is deemed essential for the outcome of patients with anticoagulation-related critical bleeding. The aim of this systematic review was to evaluate the benefits and...
3.
Sheth K, Albers G, Saver J, Campbell B, Molyneaux B, Hinson H, et al.
Lancet Neurol
. 2024 Nov;
23(12):1205-1213.
PMID: 39577921
Background: No treatment is available to prevent brain oedema, which can occur after a large hemispheric infarction. Glibenclamide has previously been shown to improve functional outcome and reduce neurological or...
4.
Theodorou A, Tsantzali I, Stefanou M, Sacco S, Katsanos A, Shoamanesh A, et al.
Eur Stroke J
. 2024 Jun;
:23969873241260538.
PMID: 38869035
Introduction: There are limited data regarding cerebrospinal fluid (CSF) and plasma biomarkers among patients with Cerebral Amyloid Angiopathy (CAA). We sought to investigate the levels of four biomarkers [β-amyloids (Aβ42...
5.
Siepen B, Polymeris A, Shoamanesh A, Connolly S, Steiner T, Poli S, et al.
Int J Stroke
. 2024 Jan;
19(5):506-514.
PMID: 38264861
Background: Data comparing the specific reversal agent andexanet alfa with non-specific treatments in patients with non-traumatic intracerebral hemorrhage (ICH) associated with factor-Xa inhibitor (FXaI) use are scarce. Aim: The study...
6.
Parry-Jones A, Jarhult S, Kreitzer N, Morotti A, Toni D, Seiffge D, et al.
Eur Stroke J
. 2023 Dec;
9(2):295-302.
PMID: 38149323
Purpose: Intracerebral haemorrhage (ICH) is the most devastating form of stroke and a major cause of disability. Clinical trials of individual therapies have failed to definitively establish a specific beneficial...
7.
Li Q, Yakhkind A, Alexandrov A, Alexandrov A, Anderson C, Dowlatshahi D, et al.
Stroke
. 2023 Dec;
55(2):494-505.
PMID: 38099439
Intracerebral hemorrhage is the most serious type of stroke, leading to high rates of severe disability and mortality. Hematoma expansion is an independent predictor of poor functional outcome and is...
8.
Eilertsen H, Menon C, Law Z, Chen C, Bath P, Steiner T, et al.
Cochrane Database Syst Rev
. 2023 Oct;
10:CD005951.
PMID: 37870112
Background: Outcome after acute spontaneous (non-traumatic) intracerebral haemorrhage (ICH) is influenced by haematoma volume. ICH expansion occurs in about 20% of people with acute ICH. Early haemostatic therapy might improve...
9.
Yogendrakumar V, Mayer S, Steiner T, Broderick J, Dowlatshahi D
Stroke
. 2023 Oct;
54(12):2990-2998.
PMID: 37805927
Background: Hematoma expansion shift (HES) analysis can be used to assess the biological effect of a hemostatic therapy for intracerebral hemorrhage. In this study, we applied HES analysis to individual...
10.
Meinel T, Wilson D, Gensicke H, Scheitz J, Ringleb P, Goganau I, et al.
JAMA Neurol
. 2023 Feb;
80(3):233-243.
PMID: 36807495
Importance: International guidelines recommend avoiding intravenous thrombolysis (IVT) in patients with ischemic stroke who have a recent intake of a direct oral anticoagulant (DOAC). Objective: To determine the risk of...